samedan logo

 
 
spacer
home > ict > summer 2019 > the service model dichotomy
PUBLICATIONS
International Clinical Trials

The Service Model Dichotomy





In the context of progressive and steady economic growth, sponsors and CROs are continually looking for the right outsourcing models to sustain their portfolios and share complementary expertise for the long term, while ensuring flexibility in the short term. Broadly speaking, outsourcing models adhere to one of the following three approaches:

  • A full-service approach using either an exclusive or dual-vendor strategy
  • Functional approaches using different strategic vendors for different service areas
  • A more ad hoc, preferred vendor approach where competitive bidding continues

While each approach has its pros and cons, the market is quickly shifting to one of dichotomy, where either functional service provision (FSP) or full-service models are the preferred option among trial sponsors.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Daniel Chapple is a Director at Quanticate and oversees a number of functions, including commercial activities. Daniel has over 20 years of experience within the drug development field, with over 15 years spent in the CRO and business process outsourcing sector. He holds a doctorate in Biochemistry, Microbiology, and Immunology from the University of London, UK, is a Fellow of the Institute of Sales Management (FISM), and is a certified ‘green belt’ in Lean Six Sigma.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Nova Biomedical Launches BioProfile® FLEX2 On-Line Autosampler for Fully Automated Sampling, Analysis, and Feedback Control of up to 10 Bioreactors

Waltham, MA – Nova Biomedical is pleased to announce the launch of the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to 3 weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability.
More info >>

White Papers

RSSL introduces same-day mycoplasma testing service in UK

RSSL

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement